03:56 AM EST, 11/13/2025 (MT Newswires) -- Helen Torley, Director, President and Chief Executive Officer, on November 10, 2025, sold 60,000 shares in Halozyme Therapeutics ( HALO ) for $4,167,930. Following the Form 4 filing with the SEC, Torley has control over a total of 733,719 common shares of the company, with 733,719 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1159036/000115903625000054/xslF345X05/wk-form4_1762991674.xml